Topics
Gliomas | Treatment | Clinical trials | Viruses
Home > Publications > Topics > Gliomas > Treatment > Clinical trials > Viruses
*Rossmeisl JH, King JN, Robertson JL, Weger-Lucarelli J,
Elankumaran S.
Phase I/II Trial of
Urokinase Plasminogen Activator-Targeted Oncolytic Newcastle
Disease Virus for Canine Intracranial Tumors.
Cancers
(Basel). 2024 Jan 29;16(3):564. doi:
10.3390/cancers16030564. PMID:
38339315. Interventional animal study. ˍ
Zeng W, Wang P, Fang S, Ge S, Jia W, Peng S, Wang M, Qin X, Zhang
W, Gao J, Su X, Yuan G, Wu J, Liu Y, Wang Y, Lu H, Mu R, Wu F,
Chang Q, Jin G, Meng F, Zhang J, Liu F.
ON-01,
an engineered recombinant oncolytic herpes simplex virus type-1,
in recurrent glioma: a single-arm, phase 1/2 study.
Neuro
Oncol. 2026 Jan 12:noag005. doi:
10.1093/neuonc/noag005. PMID:
41527280.
Trial
registration ID:
ChiCTR1900022570. ˍ